Neurodevelopmental Outcomes of Umbilical Cord Blood Transplantation in Metachromatic Leukodystrophy

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 4, 2013, Pages 616-624

  Martin, Holly R ^a   Poe, Michele D ^b   Provenzale, James M ^c   Kurtzberg, Joanne ^c   Mendizabal, Adam ^d   Escolar, Maria L ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d EMMES CORPORATION   (United States)

Author keywords

Metachromatic leukodystrophy; Neurodevelopmental function; Transplantation outcomes

Indexed keywords

ADOLESCENT; ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORRELATION ANALYSIS; DISEASE COURSE; ENGRAFTMENT; EVOKED RESPONSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; INFECTION COMPLICATION; LONGITUDINAL STUDY; MALE; METACHROMATIC LEUKODYSTROPHY; MORTALITY; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVAL; TOXICITY; TREATMENT OUTCOME;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; LEUKODYSTROPHY, METACHROMATIC; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MOTOR SKILLS; MYELOABLATIVE AGONISTS; NEURAL CONDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84875507383     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.01.010     Document Type: Article

References (27)

1. Von Figura K., Gieselmann V., Jaeken J. Metachromatic leukodystrophy. The metabolic and molecular bases of inherited disease, vol. 3 2001, 3695-3724. McGraw Hill, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
2. Kidd D., Nelson J., Jones F., et al. Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol 1998, 55:98-99.
3. Guffon N., Souillet G., Maire I., et al. Juvenile metachromatic leukodystrophy: neurological outcome two years after bone marrow transplantation. J Inherit Metab Dis 1995, 18:159-161.
4. Navarro C., Fernandez J.M., Dominguez C., et al. Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation: a 4-year follow-up study. Neurology 1996, 46:254-256.
5. Krivit W., Shapiro E., Kennedy W., et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med 1990, 322:54-55.
6. Shapiro E.G., Lipton M.E., Krivit W. White matter dysfunction and its neurophysiological correlates: longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplantation. J Clin Exp Neuropsychol 1992, 14:610-624.
7. Malm G., Ringden O., Winiarski J., et al. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 1996, 17:1003-1008.
8. Kapaun P., Dittman R.W., Granitzny B., et al. Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation. J Child Neurol 1999, 14:222-228.
9. Hoogerbrugge P.M., Brouwer O.F., Fischer A. Bone marrow transplantation for metabolic diseases with severe neurological symptoms. Bone Marrow Transplant 1991, 7(Suppl. 2):71.
10. Pridjian G., Humbert J., Willis J., et al. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J Pediatr 1994, 125:755-758.
11. Peters C., Waye J.S., Vellodi A., et al. Hematopoietic stem cell transplantation for metachromatic leukodystrophy prior to onset of clinical signs and symptoms. Correction of genetic diseases by transplantation, edition IV (COGENT IV) 1997, 34-48. Westminster Printing Press, London. O. Ringden, J.R. Hobbs, C.G. Steward (Eds.).
12. Bredius R.G., Laan L.A., Lankester A.C., et al. Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression. Bone Marrow Transplant 2007, 39:309-310.
13. Escolar M.L., Poe M.D., Provenzale J.M., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005, 352:2069-2081.
14. Staba S.L., Escolar M.L., Poe M., et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004, 350:1960-1969.
15. Beam D., Poe M.D., Provenzale J.M., et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant 2007, 13:665-674.
16. Prasad V.K., Mendizabal A., Parikh S.H., et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008, 112:2979-2989.
17. Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transplant 2009, 10:635-642.
18. Martin P.L., Carter S.L., Kernan N.A., et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated umbilical cord transplantation in pediatric patients with lysosomal and peroxisomal storage disorders. Biol Blood Marrow Transplant 2006, 12:184-194.
19. Elliott C.D. The differential ability scales (DAS) 1990, The Psychological Corporation, San Antonio, TX.
20. Mullen E. The Mullen scales of early learning 1995, American Guidance Service, Circle Pines, MN.
21. Bruininks R., Woodcock R., Weatherman R., Hill B. Scales of independent behaviour-revised 1996, Riverside Publishing Company, Chicago, IL.
22. Folio M., Fewell R. Peabody developmental motor scales 2000, Pro-Ed, Austin, TX. 2nd ed.
23. Zimmerman I., Steiner V., Pond R. Preschool language scale 2002, The Psychological Corporation, San Antonio, TX. 4th ed.
24. Semel E., Wiig E., Secord W. Clinical evaluation of language fundamentals 2003, The Psychological Corporation, San Antonio, TX. 4th ed.
25. Martin H.R., Poe M.D., Reinhartsen D., et al. Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr 2008, 97(Suppl.):69-75.
26. Loes D.J., Peters C., Krivit W. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol 1999, 20:316-323.
27. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999, 18:695-706.